KureCells Kure Cells closed pre-Series A funding round led by Waed Ventures (Aramco) alongside NantBio, US93 and Qomel rkjamvi@gmail.com October 23, 2025
KureCells UF-Kure19 granted RMAT designation by FDA based on promising efficacy for LBCL and follicular lymphoma and rapid manufacturing rkjamvi@gmail.com October 17, 2025
